SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-108279
Filing Date
2023-10-10
Accepted
2023-10-10 16:00:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2328133d1_sc13da.htm SC 13D/A 31816
  Complete submission text file 0001104659-23-108279.txt   33097
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Subject) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92695 | Film No.: 231317902
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCODE THERAPEUTICS 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address
Dudley Robert Michael (Filed by) CIK: 0001854161 (see all company filings)

Type: SC 13D/A